Decreased DNA topoisomerase IIα expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin

Oncology Research

Volumn 8, Issue 5, 1996, Pages 197-206

  Kawanami, Kiyoshi ^a,f   Nakamura, Takanori ^a   Ono, Mayumi ^a   Kusano, Toshihisa ^b   Okada, Kosuke ^c   Kikuchi, Akihiko ^d   Adachi, Noritaka ^e   Kohno, Kimitoshi ^a   Higashi, Ken ^f   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Hiroshima Women's University   (Japan)

^c H   (Japan)

^d Mitubishi Kasei Inst of Life Sci   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

cold sensitive; drug resistance; FM3A; topoisomerase; VP 16

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; IRINOTECAN; VINCRISTINE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; COLD SENSITIVITY; DRUG RESISTANCE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029796990     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1. Takano, H.; Kohno, K.; Matsuo, K.; Matsuda, T.; Kuwano, M. DNA topoisomerase-targeting antitumor agents and drug resistance. Anti-Cancer Drugs 3: 323-330; 1992.
2. 2. Beck, W. T.; Danks, M. K.; Wolverton, J. S.; Chen, M.; Granzen, B.; Kim, R.; Suttle, D. P. Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II. In: Liu, L. F., ed. DNA topoisomerases: topoisomerase-targeting drugs. San Diego; Academic Press: 1994:pp. 145-169.
3. 3. Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:351-375; 1989.
4. 4. Matsuo, K.; Kohno, K.; Takano, H.; Sato, S.; Kiue, A.; Kuwano, M. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res. 50:5819-5824; 1990.
5. 5. Takano, H.; Kohno, K.; Ono, M.; Uchida, Y.; Kuwano, M. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res. 51:3951-3957; 1991.
6. 6. Kohno, K.; Danks, M. K.; Matsuda, T.; Nitiss, J. L.; Kuwano, M.; Beck, W. T. A novel mutation of DNA topoisomerase IIα gene in an etoposide-resistant human cancer cell line. Cell. Pharmacol. 2:87-90; 1995.
7. 7. Kubo, T.; Kohno, K.; Ohga, T.; Taniguchi, K.; Kawanami, K.; Wada, M.; Kuwano, M. DNA topoisomerase IIα gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells. Cancer Res. 55, 3860-3864; 1995.
8. 8. Ishida, R.; Nishizawa, M.; Fukami, K.; Maekawa, K.; Takahashi, T.; Nishimoto, T. Isolation and characterization of novobiocin-resistant BHK cells. Somat. Cell Mol. Genet. 13:11-20; 1987.
9. 9. Matsuo, K.; Kohno, K.; Sato, S.; Uchiumi, T.; Tanimura, H.; Yamada, Y.; Kuwano, M. Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Res. 53:1085-1090; 1993.
10. 10. Kohno, K.; Tanimura, H.; Sato, S.; Nakayama, Y.; Makino, Y.; Wada, M.; Fojo, A. T.; Kuwano, M. Cellular control of human multidrug resistance 1 (MDR1) gene expression in the absence and presence of gene amplification in human cancer cells. J. Biol. Chem. 269: 20503-20508; 1994.
11. 11. Adachi, N.; Miyaike, M.; Ikeda, H.; Kikuchi, A. Characterization of cDNA encoding the mouse DNA topoisomerase II that can complement the budding yeast top2 mutation. Nucleic Acids Res. 20:5297-5303; 1992.
12. 12. Koiwai, O.; Yasui, Y.; Sakai, Y.; Watanabe, T.; Ishii, K.; Yanagihara, S.; Andoh, T. Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene. Gene 125:211-216; 1993.
13. 13. Ono, M.; Nakayama, Y.; Princler, G.; Gopas, J.; Kung, H. F.; Kuwano, M. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells. Exp. Cell Res. 203: 456-465; 1992.
14. 14. Ono, M.; Yakushinji, M.; Segawa, K.; Kuwano, M. Transformation by viral and cellular oncogenes of a mouse Balb/3T3 cell mutant resistant to transformation by chemical carcinogens. Mol. Cell. Biol. 8:4190-4196; 1988.
15. 15. Wells, N. J.; Addison, C. M.; Fry, A. M.; Ganapathi, R.; Hickson, I. D. Serine 1524 is a major site of phosphorylation on human topoisomerase IIα protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269:29746-29751; 1994.
16. 16. Litchfield, D. W.; Luscher, B. Casein kinase II in signal transduction and cell cycle regulation. Mol. Cell. Biochem. 127/128:187-199; 1993.
17. 17. Glisson, B.; Gupta, R.; Smallwood-Kentro, S.; Ross, W. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Cancer Res. 46: 1934-1938; 1986.
18. 18. Gudkov, A. V.; Zelnick, C. R.; Kazarov, A. R.; Thimmapaya, R.; Suttle, D. P.; Beck, W. T.; Roninson, I. B. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. USA 90, 3231-3235; 1993.
19. 19. Holm, C.; Stearns, T.; Botstein, D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol. Cell. Biol. 9:159-168; 1989.
20. 20. Uemura, T.; Ohkura, H.; Adachi, Y.; Morino, K.; Shiozaki, K.; Yanagida, M. DNA Topoisomerase II is required for condensation and separation of mitotic chromosome in S. pombe. Cell 50:917-925; 1987.
21. 21. Dinardo, S.; Voelkel, K.; Sternglanz, R. DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. USA 81:2616-2620; 1984.
22. 22. Ishida, R.; Sato, M.; Narita, T.; Utsumi, K. R.; Nishimoto, T.; Morita, T.; Nagata, H.; Andoh, T. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J. Cell Biol. 126:1341-1351; 1994.
23. 23. Hirose, S.; Suzuki, Y. In vitro transcription of enkaryotic genes is affected differently by the degree of DNA supercoiling. Proc. Natl. Acad. Sci. USA 85:718-722; 1988.
24. 24. Ohta, T.; Hirose, S. Purification of a DNA supercoiling factor from the posterior silk gland of Bombyx mori. Proc. Natl. Acad. Sci. USA 87:5307-531; 1990.
25. 25. Klein, F.; Laroche, T.; Cardenas, M. E.; Hotomann, F.; Schweizer, D.; Gasser, S. M. Localization of RAP1 and topoisomerase II in nuclei and meiotic chromosomes of yeast. J. Cell Biol. 117:935-948; 1992.
26. 26. Campain, J. A.; Gottesman, M. M.; Pastan, I. A novel mutant topoisomerase IIα present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429. Biochemistry 33:11327-11332; 1994.
27. 27. Tsai-Pflugfelder, M.; Liu, L. F.; Liu, A. A.; Tewey, K. M.; Whang-Peng, J.; Knutsen, T.; Huebner, K.; Croce, C. M.; Wang, J. C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci. USA 85:7177-7181; 1988.
28. 28. Tan, K. B.; Dorman, T. E.; Falls, K. M.; Chung, T. D. Y.; Mirabelli, C. K.; Crooke, S. T.; Mao, J. Topoisomerase IIα and topoisomerase IIβ genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res. 52:231-234; 1992.
29. 29. Harker, W. G.; Slade, D. L.; Parr, R. L.; Feldhoff, P. W.; Sullivan, D. M.; Holguin, M.H. Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res. 55:1707-1716; 1995.